跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DAPTOMICINA ACCORD HEALTHCARE 350 MG POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DAPTOMICINA ACCORD HEALTHCARE 350 MG POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN EFG
Approved
STANDARD
DAPTOMICINA ACCORD HEALTHCARE 350 MG POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN EFG
Accord Healthcare S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 18, 2024
Approval ID
f939d2c7d11c2f6a
Company
Accord Healthcare S.L.U.
Type
Standard
Approval Details
Approval Id
f939d2c7d11c2f6a
Drug Cima Aemps Name
DAPTOMICINA ACCORD HEALTHCARE 350 MG POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN EFG
Register Number
89243
Holder Company Name
Accord Healthcare S.L.U.
Marketing Company Name
Accord Healthcare S.L.U.
Holder Company Detail Path
/organization/accord-healthcare-sl
Marketing Company Detail Path
/organization/accord-healthcare-sl
Authorization Date
2024-01-18
Dosage Form
POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN
Dose
350 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Accord Healthcare S.L.U.
Company Detail Path
/organization/accord-healthcare-sl
Company Information
Pharmaceutical Company Name
ACCORD HEALTHCARE SL
Country Name
Spain
City Name
barcelona,barcelona,country_es
Address
CALLE MOLL BARCELONA (WORLD TRADE CENTER EDIF. ESTE), S/N
Active Ingredients
DAPTOMICINA
350 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 18, 2024
Approval ID
f939d2c7d11c2f6a
Type
Standard
Back to CIMA-AEMPS Approvals